Skip to main content
Log in

Postconditioning and intermittent bradykinin induced cardioprotection require cyclooxygenase activation and prostacyclin release during reperfusion

  • ORIGINAL CONTRIBUTION
  • Published:
Basic Research in Cardiology Aims and scope Submit manuscript

Abstract

Postconditioning (PostC), obtained with brief intermittent cycles of ischemia alternating with reperfusion applied after the ischemic event, has been shown to reduce infarct size. Recently, we have shown that PostC triggering includes B2 receptor activation and its downstream pathway. Moreover, we showed that BK intermittent infusion induces a cardioprotection similar to PostC. The aim of this study was to investigate the involvement of cyclooxygenase-(COX)-derivated prostaglandins, such as prostacyclin (PGI2) pathway in the cardioprotective action mediated by intermittent BK infusion.

Isolated rat hearts underwent 30 min ischemia and 120 min reperfusion. Myocardial damage was evaluated using nitro-blue-tetrazolium staining. The production of metabolite of PGI2, 6-keto-PGF1α, was evaluated with EIA assay on the samples collected during reperfusion. The perfusion pressure and the left ventricular pressure were monitored. In Control hearts, the infarct size was 64% ± 4% of risk area. PostC reduced significantly the infarct size (28% ± 4% P < 0.001 Vs. Control). BK intermittent protocol to mimic PostC, attenuated infarct size (40% ± 2% P < 0.01 Vs. Control). The BK-intermittent and PostC protections were abolished with COX-inhibition. Intermittent BK and PostC enhanced the release of prostacyclin metabolite, 6-keto-PGF1α, in the late phase of reperfusion (i.e., 6-keto-PGF1α peaked 30 min after protective maneuvers). Also the stable PGI2 analogue, Iloprost, given in the early reperfusion reduced infarct size and improved post-ischemic heart function. In conclusion, protection by PostC and intermittent BK requires COX activation and PGI2 release during late reperfusion. These data suggest that COX must not be inhibited to have PostC protection. This finding should be kept present by future clinical studies on PostC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Berti F, Rossoni G, Magni F, Caruso D, Omini C, Puglisi L, Galli G (1988) Nonsteroidal antiinflammatory drugs aggravate acute myocardial ischemia in the perfused rabbit heart: a role for prostacyclin. J Cardiovas Pharmacol 12:438–444

    Article  CAS  Google Scholar 

  2. Boengler K, Buechert A, Heinen Y, Roeskes C, Hilfiker-Kleiner D, Heusch G, Schulz R (2008) Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circ Res 102:131–135

    Article  PubMed  CAS  Google Scholar 

  3. Cohen MV, Yang XM, Downey JM (2007) The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation 115:1895–1903

    Article  PubMed  Google Scholar 

  4. Darling CE, Solari PB, Smith CS, Furman MI, Przyklenk K (2007) ‘Postconditioning’ the human heart: multiple balloon inflations during primary angioplasty may confer cardioprotection. Basic Res Cardiol 102:274–278

    Article  PubMed  Google Scholar 

  5. Dow J, Kloner RA (2007) Postconditioning does not reduce myocardial infarct size in an in vivo regional ischemia rodent model. J Cardiovasc Pharmacol Ther 12:153–163

    Article  PubMed  Google Scholar 

  6. Engels W, Van Bilsen M, De Groot MJ, Lemmens PJ, Willemsen PH, Reneman RS, Van der Vusse GJ (1990) Ischemia and reperfusion induced formation of eicosanoids in isolated rat hearts. Am J Physiol 258:H1865–H1871

    PubMed  CAS  Google Scholar 

  7. Farber NE, Gross GJ (1989) Prostaglandin E1 attenuates postischemic contractile dysfunction after brief coronary occlusion and reperfusion. Am Heart J 118:17–24

    Article  PubMed  CAS  Google Scholar 

  8. Farber NE, Pieper GM, Thomas JP, Gross GJ (1988) Beneficial effects of iloprost in the stunned canine myocardium. Circ Res 62:204–215

    PubMed  CAS  Google Scholar 

  9. Gelpi RJ, Morales C, Cohen MV, Downey JM (2002) Xanthine oxidase contributes to preconditioning’s preservation of left ventricular developed pressure in isolated rat heart: developed pressure may not be an appropriate end-point for studies of preconditioning. Basic Res Cardiol 97:40–46

    Article  PubMed  CAS  Google Scholar 

  10. Gres P, Schulz R, Jansen J, Umschlag C, Heusch G (2002) Involvement of endogenous prostaglandins in ischemic preconditioning in pigs. Cardiovasc Res 55:626–632

    Article  PubMed  CAS  Google Scholar 

  11. Grosser T, Fries S, FitzGerald GA (2006) Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest 116:4–15

    Article  PubMed  CAS  Google Scholar 

  12. Hausenloy DJ, Tsang A, Yellon DM (2005) The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med 15:69–75

    Article  PubMed  CAS  Google Scholar 

  13. Heusch G, Buchert A, Feldhaus S, Schulz R (2006) No loss of cardioprotection by postconditioning in connexin 43-deficient mice. Basic Res Cardiol 101:354–356

    Article  PubMed  CAS  Google Scholar 

  14. Hilgenfeldt U, Stannek C, Lukasova M, Schnolzer M, Lewicka S (2005) Rat tissue kallikrein releases a kallidin-like peptide from rat low-molecular-weight kininogen. Br J Pharmacol 146:958–963

    Article  PubMed  CAS  Google Scholar 

  15. Kerendi F, Kin H, Halkos ME, Jiang R, Zatta AJ, Zhao ZQ, Guyton RA, Vinten-Johansen J (2005) Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors. Basic Res Cardiol 100:404–412

    Article  PubMed  CAS  Google Scholar 

  16. Kin H, Zatta AJ, Lofye MT, Amerson BS, Halkos ME, Kerendi F, Zhao ZQ, Guyton RA, Headrick JP, Vinten-Johansen J (2005) Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc Res 67:124–133

    Article  PubMed  CAS  Google Scholar 

  17. Leesar MA, Stoddard MF, Manchikalapudi S, Bolli R (1999) Bradykinin-induced preconditioning in patients undergoing coronary angioplasty. J Am Coll Cardiol 34:639–660

    Article  PubMed  CAS  Google Scholar 

  18. Liu X, Lukasova M, Zubakova R, Lewicka S, Hilgenfeldt U (2005) A kallidin-like peptide is a protective cardiac kinin, released by ischaemic preconditioning of rat heart. Br J Pharmacol 146:952–957

    Article  PubMed  CAS  Google Scholar 

  19. Liu X, Lukasova M, Zubakova R, Lewicka S, Hilgenfeldt U (2006) Kallidin-like peptide mediates the cardioprotective effect of the ACE inhibitor captopril against ischaemic reperfusion injury of rat heart. Br J Pharmacol 148:825–832

    Article  PubMed  CAS  Google Scholar 

  20. Lochner A, Genade S, Moolman JA (2003) Ischemic preconditioning: infarct size is a more reliable endpoint than functional recovery. Basic Res Cardiol 98:337–346

    Article  PubMed  CAS  Google Scholar 

  21. Mykytenko J, Kerendi F, Reeves JG, Kin H, Zatta AJ, Jiang R, Guyton RA,Vinten-Johansen J, Zhao ZQ (2007) Long-term inhibition of myocardial infarction by postconditioning during reperfusion. Basic Res Cardiol 102:90–100

    Article  PubMed  CAS  Google Scholar 

  22. Pagliaro P, Mancardi D, Rastaldo R, Penna C, Gattullo D, Miranda KM, Feelisch M, Wink DA, Kass DA, Paolocci N (2003) Nitroxyl affords thiol-sensitive myocardial protective effects akin to early preconditioning. Free Radic Biol Med 34:33–43

    Article  PubMed  CAS  Google Scholar 

  23. Penna C, Cappello S, Mancardi D, Raimondo S, Rastaldo R, Gattullo D, Losano G, Pagliaro P (2006) Post-conditioning reduces infarct size in the isolated rat heart: role of coronary flow and pressure and the nitric oxide/cGMP pathway. Basic Res Cardiol 101:168–179

    Article  PubMed  CAS  Google Scholar 

  24. Penna C, Mancardi D, Rastaldo R, Losano G, Pagliaro P (2007) Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling. Cardiovasc Res 75:168–177

    Article  PubMed  CAS  Google Scholar 

  25. Penna C, Rastaldo R, Mancardi D, Raimondo S, Cappello S, Gattullo D, Losano G, Pagliaro P (2006) Post-conditioning induced cardioprotection requires signaling through a redox-sensitive mechanism, mitochondrial ATP-sensitive K+ channel and protein kinase C activation (see comment). Basic Res Cardiol 101:180–189

    Article  PubMed  CAS  Google Scholar 

  26. Philipp S, Yang XM, Cui L, Davis AM, Downey JM, Cohen MV (2006) Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade. Cardiovasc Res 70:308–314

    Article  PubMed  CAS  Google Scholar 

  27. Rastaldo R, Paolocci N, Chiribiri A, Penna C, Gattullo D, Pagliaro P (2001) Cytochrome P-450 metabolite of arachidonic acid mediates bradykinin-induced negative inotropic effect. Am J Physiol Heart Circ Physiol 280:H2823–H2832

    PubMed  CAS  Google Scholar 

  28. Rossoni G, Berti M, Colonna VD, Bernareggi M, Del Soldato P, Berti F (2000) Myocardial protection by the nitroderivative of aspirin, NCX 4016: in vitro and in vivo experiments in the rabbit. Ital Heart J 1:146–155

    PubMed  CAS  Google Scholar 

  29. Sato H, Bolli R, Rokosh GD, Bi Q, Dai S, Shirk G, Tang XL (2007) The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2-mediated mechanism in conscious rats. Am J Physiol Heart Circ Physiol 293:H2557–2564

    Article  PubMed  CAS  Google Scholar 

  30. Schulz R, Post H, Vahlhaus C, Heusch G (1998) Ischemic preconditioning in pigs: a graded phenomenon: its relation to adenosine and bradykinin. Circulation 98:1022–1029

    PubMed  CAS  Google Scholar 

  31. Sivaraman V, Mudalgiri NR, Di Salvo C, Kolvekar S, Hayward M, Yap J, Keogh B, Hausenloy DJ, Yellon DM (2007) Postconditioning protects human atrial muscle through the activation of the RISK pathway. Basic Res Cardiol 102:453–459

    Article  PubMed  Google Scholar 

  32. Staat P, Rioufol G, Piot C, Piot C, Cottin Y, Cung TT, L’Huillier I, Aupetit JF, Bonnefoy E, Finet G, Andre-Fouet X, Ovize M (2005) Postconditioning the human heart. Circulation 112:2143–2148

    Article  PubMed  Google Scholar 

  33. van Bilsen M, Engels W, van der Vusse GJ, Reneman RS (1989) Significance of myocardial eicosanoid production. Mol Cell Biochem 88:113–121

    Article  PubMed  Google Scholar 

  34. Veeravalli KK, Akula A, Kota MK (2003) Nitric oxide- and prostaglandin-mediated cardioprotection by bradykinin in myocardial ischemia and reperfusion injury. Pol J Pharmacol 55:1021–1029

    PubMed  CAS  Google Scholar 

  35. Vinten-Johansen J, Zhao ZQ, Zatta AJ, Kin H, Halkos ME, Kerendi F (2005) Postconditioning–a new link in nature’s armor against myocardial ischemia–reperfusion injury. Basic Res Cardiol 100:295–310

    Article  PubMed  CAS  Google Scholar 

  36. Yang XM, Downey JM, Cohen MV (2005) Postconditioning’s protection is not dependent on circulating blood factors or cells but requires PI3-kinase and guanylyl cyclase activation. Basic Res Cardiol 100:57–63

    Article  PubMed  CAS  Google Scholar 

  37. Yang XP, Liu YH, Scicli GM, Webb CR, Carretero OA (1997) Role of kinins in the cardioprotective effect of preconditioning: study of myocardial ischemia/reperfusion injury in B2 kinin receptor knockout mice and kininogen-deficient rats. Hypertension 30:735–740

    PubMed  CAS  Google Scholar 

  38. Yellon DM, Opie LH (2006) Postconditioning for protection of the infarcting heart. Lancet 367:456–458

    Article  PubMed  Google Scholar 

  39. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J (2003) Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. (erratum appears in Am J Physiol Heart Circ Physiol. 2004 Jan;286(1):H477). Am J Physiol Heart Circ Physiol 285:H579–H588

    Google Scholar 

  40. Zhao ZQ, Vinten-Johansen J (2006) Postconditioning: reduction of reperfusion-induced injury. Cardiovasc Res 70:200–211

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Regione Piemonte; Compagnia di San Paolo”; the Consorzio Interuniversitario per le Ricerche Cardiovascolari (CIRC) and the Italian Ministry of University and Research (MIUR, PRIN). We Thank Dr. Giovanni Berta for insightful suggestions.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pasquale Pagliaro.

Additional information

Returned for 1. Revision: 6 August 2007 1. Revision received: 16 November 2007

Returned for 2. Revision: 22 November 2007 2. Revision received: 23 November 2007

Rights and permissions

Reprints and permissions

About this article

Cite this article

Penna, C., Mancardi, D., Tullio, F. et al. Postconditioning and intermittent bradykinin induced cardioprotection require cyclooxygenase activation and prostacyclin release during reperfusion. Basic Res Cardiol 103, 368–377 (2008). https://doi.org/10.1007/s00395-007-0695-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00395-007-0695-7

Keywords

Navigation